Glycomics Market Insights, 2021-2031

Glycomics Market (Product Type: Enzymes, Instruments, Kits, and Reagents; Application: Diagnostics, Drug Discovery & Development, Oncology, Immunology, and Others; and End-user: Academic Research Institutes, Pharmaceutical and & Biotechnology Companies, and Contract Research Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Accelerating Glycomics Market During COVID-19 Outbreak

The increasing number of patients suffering from chronic diseases is anticipated to revive the growth of the global glycomics market. The market is expected to witness abundance of growth opportunities in the upcoming years. The increasing presence of pharmaceutical companies and research institutes to boost the drug discovery and development sector is driving the global glycomics market. Advancements in this field have played a major role in drug investigation during coronavirus pandemic. Technological advancements on biotechnology, investments on R&D activities to study gycans or polysaccharides, and increasing applications in disease diagnostics are creating revenue opportunities amid pandemic in the global market.

global glycomics market infographic

Request a sample to get extensive insights into the Glycomics Market

Surging Demand for Pharmaceutical Drugs and Treatments Globally

The global glycomics market is projected to cross US$ 3.1 Bn by 2031. The increasing demand for treatments for various chronic diseases is fueling the growth of the global glycomics market. Pharmaceutical companies are paving their ways in the global market to support R&D activities in glycans to generate more revenue opportunities. Increasing government expenditure on healthcare as well as in research & development activities in bioinformatics strengthen the scope and expansion of the market. Since cancer is one of the leading causes of death, there is an increasing focus of market contributors to support drug discovery and development activities in the field of oncology to create profitable opportunities.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Government Initiatives to Support and Invest in R&D Activities

Glycomics is the study of structure, biology, and function of saccharides or glycans, which can be found in all living organisms. The application of glycobiology in drug discovery & development, disease diagnostics, oncology, immunology, etc. has created tremendous growth opportunities for the players operating in the global market. The global glycomics market is expected to expand at a CAGR of 11.2% during the forecast period of 2021-2031. Pharmaceutical companies are increasing their output capacities to support the global glycomics market. Governments are taking steps ahead to support manufacturers in the pharmaceutical companies, and investing in R&D activities. The increasing healthcare expenditure by governments of developing countries to support research activities in the global market help fuel market growth.

Expansion of Academic & Research Institutes to Support Market Growth

Growth and advancement academic & research institutes to study glycomics, which has many applications in rapid development of drugs, vaccine development, and precision medicines, are factors expected to drive the global market during the forecast period. Increasing collaborations between research institutions and key market contributors to support research activities in biomedical and biochemistry are responsible for generating revenue streams. Expanding contact research organizations in pharmaceuticals to outsource R&D activities to stay ahead of the competition help grow manufactures operating in the global glycomics market. Increasing collaborate activities of market players and research institutes to study proteomics and glycomics to discover solutions on genetic diseases drives the global glycomics market.

global glycomics market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Glycomics Market

Analysts’ Viewpoint

There is a growing need of research and development activities in the field of glycan to study and understand the drug development lifecycle. Rising prevalence of chronic diseases such as cancer and diabetes, etc., technological advancements in pharmaceutical industry, and increasing research activities in the field of biotechnology to study the glycans are factors expected to create lucrative revenue opportunities for the global glycomics market players. However, there are still some challenges that need to be consider about the high costs of tools. Increasing investments on healthcare and presence of highly advanced research laboratories in the region are some of the factors responsible for the flourishing growth in North America.

Glycomics Market: Overview

  • This report analyzes the current scenario and future prospects of the global glycomics market. Growth of the global glycomics market is driven by increase in research activities on glycomics and rise in R&D investments in pharmaceutical and biotechnology companies.
  • The report provides an elaborate executive summary, including a snapshot of various segments of the global glycomics market. It also provides elaborate information and data analysis of the global glycomics market with regard to segments based on product type, application, end-user, and region.
  • The overview section of the report provides a detailed qualitative analysis of the drivers and restraints, and opportunities that affect the global glycomics market
  • Additionally, the report includes company profiles, which provide information about their business, product portfolios, and competition landscape in the glycomics market
  • The report on the global glycomics market offers market attractiveness analysis of the regions and segments
  • The last section of the report comprises quantitative and qualitative analysis on market share/position of key players operating in the global glycomics market. It analyzes the key competitive strategies adopted by the major industry players, thereby presenting a thorough understanding of the competitive scenario in the global glycomics market.

Glycomics Market: Key Segments

  • In terms of product type, the global glycomics market has been classified into enzymes, instruments, kits, and reagents. The enzymes segment accounted for major share of the global glycomics market in 2020, and the trend is anticipated to continue during the forecast period.
  • Based on application, the global glycomics market has been categorized into diagnostics, drug discovery & development, oncology immunology, and others
  • In terms of end-user, the global glycomics market has been divided into academic research institutes, pharmaceutical & biotechnology companies, and contract research organizations
  • The market value and forecast for each of these segments have been provided from 2017 to 2031. The CAGR of respective segments has also been provided from 2021 to 2031, considering 2017 to 2019 as the historical years and 2020 as the base year.

Glycomics Market: Regional Outlook

  • The global glycomics market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
  • The glycomics market report provides value and forecast for each region and country/sub-region from 2017 to 2031. The compound annual growth rates (CAGRs) for each of these regions and countries have also been provided for the forecast period from 2021 to 2031. The glycomics market study also covers the competitive scenario in these regions.

Companies Mentioned in Report

  • Key players in the global glycomics market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the global glycomics market report are
    • Agilent Technologies, Inc.
    • Asparia Glycomics
    • Bruker Corporation
    • Canadian Glycomics Network (GLYCONET)
    • Glyco Expression Technologies, Inc.
    • Glycodiag
    • Merck KGaA
    • New England Biolabs
    • RayBiotech, Inc.
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Vector Laboratories
    • Glyde Bio, Inc.

Glycomics Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 0.9 Bn

Market Forecast Value in 2031

US$ 3.1 Bn

Growth Rate (CAGR)

11.2%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Additionally, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, supply chain analysis, and parent industry overview.

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product Type
    • Enzymes
      • Glycosidases
      • Glycosyltransferases
      • Neuraminidases
      • Sialyltransferases
      • Others
    • Instruments
      • Antibody Arrays
      • HPLC
      • Lectin Arrays
      • MALDI-TOF
      • Other Glycomics Instruments
    • Kits
      • Glycan Labeling Kits
      • Glycan Purification Kits
      • Glycan Release Kits
      • Others
    • Reagents
      • Glycoproteins
      • Monosaccharides
      • Oligosaccharides
      • Others
  • Application
    • Diagnostics
    • Drug Discovery & Development
    • Oncology
    • Immunology
    • Others
  • End User
    • Academic Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Contract Research Organizations

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Japan
  • China
  • India
  • Australia
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Customization Scope

Available upon request

Pricing

Available upon request

Glycomics Market – Segmentation

Product Type
  • Enzymes
    • Glycosidases
    • Glycosyltransferases
    • Neuraminidases
    • Sialyltransferases
    • Others
  • Instruments
    • Antibody Arrays
    • HPLC
    • Lectin Arrays
    • MALDI-TOF
    • Other Glycomics Instruments
  • Kits
    • Glycan Labeling Kits
    • Glycan Purification Kits
    • Glycan Release Kits
    • Others
  • Reagents
    • Glycoproteins
    • Monosaccharides
    • Oligosaccharides
    • Others
Application
  • Diagnostics
  • Drug Discovery & Development
  • Oncology
  • Immunology
  • Others
End-user
  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of glycomics market?

The global glycomics market was worth US$ 0.9 Bn and is projected to reach a value of US$ 3.1 Bn by the end of 2031

What is the anticipated CAGR of the glycomics market in the forecast period?

Glycomics market is anticipated to grow at a CAGR of 11.2% during the forecast period

Which region is expected to project the highest market share in the glycomics market?

North America accounted for a major share of the global glycomics market

What are the key driving factors for growth of glycomics market?

Global glycomics market is driven by increase in research activities on glycomics and rise in R&D investments in pharmaceutical and biotechnology companies

Who are the key players in the global glycomics market?

Key players in the global glycomics market include Agilent Technologies, Inc., Asparia Glycomics, Bruker Corporation, Canadian Glycomics Network (GLYCONET), Glyco Expression Technologies, Inc., Glycodiag, Merck KGaA, New England Biolabs, RayBiotech, Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Vector Laboratories, and Glyde Bio, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Glycomics Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Type Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Glycomics Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.)

        5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

        5.3. Technological Advancements

    6. Global Glycomics Market Analysis and Forecast, by Product Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Product Type, 2017–2031

            6.3.1. Enzymes

                6.3.1.1. Glycosidases

                6.3.1.2. Glycosyltransferases

                6.3.1.3. Neuraminidases

                6.3.1.4. Sialyltransferases

                6.3.1.5. Others

            6.3.2. Instruments

                6.3.2.1. Antibody Arrays

                6.3.2.2. HPLC

                6.3.2.3. Lectin Arrays

                6.3.2.4. MALDI-TOF

                6.3.2.5. Other Glycomics Instruments

            6.3.3. Kits

                6.3.3.1. Glycan Labeling Kits

                6.3.3.2. Glycan Purification Kits

                6.3.3.3. Glycan Release Kits

                6.3.3.4. Others

            6.3.4. Reagents

                6.3.4.1. Glycoproteins

                6.3.4.2. Monosaccharides

                6.3.4.3. Oligosaccharides

                6.3.4.4. Others

        6.4. Market Attractiveness Analysis, by Product Type

    7. Global Glycomics Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Diagnostics

            7.3.2. Drug Discovery & Development

            7.3.3. Oncology

            7.3.4. Immunology

            7.3.5. Others

        7.4. Market Attractiveness Analysis, by Application

    8. Global Glycomics Market Analysis and Forecast End-user

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by End-user, 2017–2031

            8.3.1. Academic Research Institute

            8.3.2. Pharmaceutical & Biotechnology Companies

            8.3.3. Contract Research Organizations

        8.4. Market Attractiveness Analysis, by End-user

    9. Global Glycomics Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region

            9.2.1. North America

            9.2.2. Europe 

            9.2.3. Asia Pacific 

            9.2.4. Latin America 

            9.2.5. Middle East & Africa 

        9.3. Market Attractiveness Analysis, by Country/Region

    10. North America Glycomics Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Product Type, 2017–2031

            10.2.1. Enzymes

                10.2.1.1. Glycosidases

                10.2.1.2. Glycosyltransferases

                10.2.1.3. Neuraminidases

                10.2.1.4. Sialyltransferases

                10.2.1.5. Others

            10.2.2. Instruments

                10.2.2.1. Antibody Arrays

                10.2.2.2. HPLC

                10.2.2.3. Lectin Arrays

                10.2.2.4. MALDI-TOF

                10.2.2.5. Other Glycomics Instruments

            10.2.3. Kits

                10.2.3.1. Glycan Labeling Kits

                10.2.3.2. Glycan Purification Kits

                10.2.3.3. Glycan Release Kits

                10.2.3.4. Others

            10.2.4. Reagents

                10.2.4.1. Glycoproteins

                10.2.4.2. Monosaccharides

                10.2.4.3. Oligosaccharides

                10.2.4.4. Others

        10.3. Market Value Forecast, by Application, 2017–2031

            10.3.1. Diagnostics

            10.3.2. Drug Discovery & Development

            10.3.3. Oncology

            10.3.4. Immunology

            10.3.5. Others

        10.4. Market Value Forecast, by End-user, 2017–2031

            10.4.1. Academic Research Institute

            10.4.2. Pharmaceutical & Biotechnology Companies

            10.4.3. Contract Research Organizations

        10.5. Market Value Forecast, by Country, 2017–2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Product Type

            10.6.2. By Application

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Glycomics Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Product Type, 2017–2031

            11.2.1. Enzymes

                11.2.1.1. Glycosidases

                11.2.1.2. Glycosyltransferases

                11.2.1.3. Neuraminidases

                11.2.1.4. Sialyltransferases

                11.2.1.5. Others

            11.2.2. Instruments

                11.2.2.1. Antibody Arrays

                11.2.2.2. HPLC

                11.2.2.3. Lectin Arrays

                11.2.2.4. MALDI-TOF

                11.2.2.5. Other Glycomics Instruments

            11.2.3. Kits

                11.2.3.1. Glycan Labeling Kits

                11.2.3.2. Glycan Purification Kits

                11.2.3.3. Glycan Release Kits

                11.2.3.4. Others

            11.2.4. Reagents

                11.2.4.1. Glycoproteins

                11.2.4.2. Monosaccharides

                11.2.4.3. Oligosaccharides

                11.2.4.4. Others

        11.3. Market Value Forecast Application, 2017–2031

            11.3.1. Diagnostics

            11.3.2. Drug Discovery & Development

            11.3.3. Oncology

            11.3.4. Immunology

            11.3.5. Others

        11.4. Market Value Forecast, by End-user, 2017–2031

            11.4.1. Academic Research Institute

            11.4.2. Pharmaceutical & Biotechnology Companies

            11.4.3. Contract Research Organizations

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. U.K.

            11.5.2. Germany

            11.5.3. France

            11.5.4. Spain

            11.5.5. Italy

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Product Type

            11.6.2. By Application

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Glycomics Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Product Type, 2017–2031

            12.2.1. Enzymes

                12.2.1.1. Glycosidases

                12.2.1.2. Glycosyltransferases

                12.2.1.3. Neuraminidases

                12.2.1.4. Sialyltransferases

                12.2.1.5. Others

            12.2.2. Instruments

                12.2.2.1. Antibody Arrays

                12.2.2.2. HPLC

                12.2.2.3. Lectin Arrays

                12.2.2.4. MALDI-TOF

                12.2.2.5. Other Glycomics Instruments

            12.2.3. Kits

                12.2.3.1. Glycan Labeling Kits

                12.2.3.2. Glycan Purification Kits

                12.2.3.3. Glycan Release Kits

                12.2.3.4. Others

            12.2.4. Reagents

                12.2.4.1. Glycoproteins

                12.2.4.2. Monosaccharides

                12.2.4.3. Oligosaccharides

                12.2.4.4. Others

        12.3. Market Value Forecast, by Application, 2017–2031

            12.3.1. Diagnostics

            12.3.2. Drug Discovery & Development

            12.3.3. Oncology

            12.3.4. Immunology

            12.3.5. Others

        12.4. Market Value Forecast, by End-user, 2017–2031

            12.4.1. Academic Research Institute

            12.4.2. Pharmaceutical & Biotechnology Companies

            12.4.3. Contract Research Organizations

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. China

            12.5.2. India

            12.5.3. Japan

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Product Type

            12.6.2. By Application

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Glycomics Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Product Type, 2017–2031

            13.2.1. Enzymes

                13.2.1.1. Glycosidases

                13.2.1.2. Glycosyltransferases

                13.2.1.3. Neuraminidases

                13.2.1.4. Sialyltransferases

                13.2.1.5. Others

            13.2.2. Instruments

                13.2.2.1. Antibody Arrays

                13.2.2.2. HPLC

                13.2.2.3. Lectin Arrays

                13.2.2.4. MALDI-TOF

                13.2.2.5. Other Glycomics Instruments

            13.2.3. Kits

                13.2.3.1. Glycan Labeling Kits

                13.2.3.2. Glycan Purification Kits

                13.2.3.3. Glycan Release Kits

                13.2.3.4. Others

            13.2.4. Reagents

                13.2.4.1. Glycoproteins

                13.2.4.2. Monosaccharides

                13.2.4.3. Oligosaccharides

                13.2.4.4. Others

        13.3. Market Value Forecast, by Application, 2017–2031

            13.3.1. Diagnostics

            13.3.2. Drug Discovery & Development

            13.3.3. Oncology

            13.3.4. Immunology

            13.3.5. Others

        13.4. Market Value Forecast, by End-user, 2017–2031

            13.4.1. Academic Research Institute

            13.4.2. Pharmaceutical & Biotechnology Companies

            13.4.3. Contract Research Organizations

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Product Type

            13.6.2. By Application

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Glycomics Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Product Type, 2017–2031

            14.2.1. Enzymes

                14.2.1.1. Glycosidases

                14.2.1.2. Glycosyltransferases

                14.2.1.3. Neuraminidases

                14.2.1.4. Sialyltransferases

                14.2.1.5. Others

            14.2.2. Instruments

                14.2.2.1. Antibody Arrays

                14.2.2.2. HPLC

                14.2.2.3. Lectin Arrays

                14.2.2.4. MALDI-TOF

                14.2.2.5. Other Glycomics Instruments

            14.2.3. Kits

                14.2.3.1. Glycan Labeling Kits

                14.2.3.2. Glycan Purification Kits

                14.2.3.3. Glycan Release Kits

                14.2.3.4. Others

            14.2.4. Reagents

                14.2.4.1. Glycoproteins

                14.2.4.2. Monosaccharides

                14.2.4.3. Oligosaccharides

                14.2.4.4. Others

        14.3. Market Value Forecast, by Application, 2017–2031

            14.3.1. Diagnostics

            14.3.2. Drug Discovery & Development

            14.3.3. Oncology

            14.3.4. Immunology

            14.3.5. Others

        14.4. Market Value Forecast, by End-user, 2017–2031

            14.4.1. Academic Research Institute

            14.4.2. Pharmaceutical & Biotechnology Companies

            14.4.3. Contract Research Organizations

        14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Product Type

            14.6.2. By Application

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix

        15.2. Market Share Analysis, by Company, 2020

        15.3. Competitive Business Strategies

        15.4. Company Profiles

            15.4.1. Agilent Technologies, Inc.

                15.4.1.1. Company Description

                15.4.1.2. Business Overview

                15.4.1.3. Financial Overview

                15.4.1.4. SWOT Analysis

            15.4.2. Asparia Glycomics

                15.4.2.1. Company Description

                15.4.2.2. SWOT Analysis

            15.4.3. Bruker Corporation

                15.4.3.1. Company Description

                15.4.3.2. Business Overview

                15.4.3.3. Financial Overview

                15.4.3.4. SWOT Analysis

            15.4.4. Canadian Glycomics Network (GLYCONET)

                15.4.4.1. Company Description

                15.4.4.2. Business Overview

                15.4.4.3. SWOT Analysis

            15.4.5. Glyco Expression Technologies, Inc.

                15.4.5.1. Company Description

                15.4.5.2. SWOT Analysis

            15.4.6. Glycodiag

                15.4.6.1. Company Description

                15.4.6.2. Business Overview

                15.4.6.3. SWOT Analysis

            15.4.7. Merck KGaA

                15.4.7.1. Company Description

                15.4.7.2. Business Overview

                15.4.7.3. Financial Overview

                15.4.7.4. SWOT Analysis

            15.4.8. New England Biolabs

                15.4.8.1. Company Description

                15.4.8.2. Business Overview

                15.4.8.3. SWOT Analysis

            15.4.9. RayBiotech, Inc.

                15.4.9.1. Company Description

                15.4.9.2. SWOT Analysis

            15.4.10. Shimadzu Corporation

                15.4.10.1. Company Description

                15.4.10.2. Business Overview

                15.4.10.3. Financial Overview

                15.4.10.4. SWOT Analysis

            15.4.11. Thermo Fisher Scientific, Inc.

                15.4.11.1. Company Description

                15.4.11.2. Business Overview

                15.4.11.3. Financial Overview

                15.4.11.4. SWOT Analysis

            15.4.12. Vector Laboratories

                15.4.12.1. Company Description

                15.4.12.2. Business Overview

                15.4.12.3. SWOT Analysis

            15.4.13. Glyde Bio, Inc.

                15.4.13.1. Company Description

                15.4.13.2. SWOT Analysis

    List of Tables

    Table 01: Global Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 02: Global Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

    Table 03: Global Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

    Table 04: Global Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

    Table 05: Global Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

    Table 06: Global Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 07: Global Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 08: Global Glycomics Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 09: North America Glycomics Market Analysis Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 10: North America Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 11: North America Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

    Table 12: North America Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

    Table 13: North America Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

    Table 14: North America Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

    Table 15: North America Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 16: North America Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 17: Europe Glycomics Market Analysis Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Europe Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 19: Europe Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

    Table 20: Europe Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

    Table 21: Europe Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

    Table 22: Europe Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

    Table 23: Europe Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 24: Europe Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 25: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 26: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 27: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

    Table 28: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

    Table 29: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

    Table 30: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

    Table 31: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 32: Asia Pacific Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 33: Latin America Glycomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 34: Latin America Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 35: Latin America Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

    Table 36: Latin America Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

    Table 37: Latin America Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

    Table 38: Latin America Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

    Table 39: Latin America Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 40: Latin America Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    Table 41: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 42: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Product Type, 2017–2031

    Table 43: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Enzymes, 2017–2031

    Table 44: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Instruments, 2017–2031

    Table 45: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Kits, 2017–2031

    Table 46: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Reagents, 2017–2031

    Table 47: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by Application, 2017-2031

    Table 48: Middle East & Africa Glycomics Market Value (US$ Mn) Forecast, by End-user, 2017-2031

    List of Figures

    Figure 01: Global Glycomics Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Glycomics Market Value Share, by Product Type, 2020

    Figure 03: Global Glycomics Market Value Share, by Application, 2020

    Figure 04: Global Glycomics Market Value Share, by End-user, 2020

    Figure 05: Global Glycomics Market Value Share, by Region, 2020

    Figure 06: Global Glycomics Market Value Share Analysis, by Product Type, 2020 and 2031

    Figure 07: Global Glycomics Market Attractiveness Analysis, by Product Type , 2021–2031

    Figure 08: Global Glycomics Market Revenue (US$ Mn), by Enzymes, 2017–2031

    Figure 09: Global Glycomics Market Revenue (US$ Mn), by Instruments, 2017–2031

    Figure 10: Global Glycomics Market Revenue (US$ Mn), by Kits, 2017–2031

    Figure 11: Global Glycomics Market Revenue (US$ Mn), by Reagents, 2017–2031

    Figure 12: Global Glycomics Market Value Share Analysis, by Application, 2020 and 2031

    Figure 13: Global Glycomics Market Attractiveness Analysis, by Application, 2021–2031

    Figure 14: Global Glycomics Market Revenue (US$ Mn), by Diagnostics, 2017–2031

    Figure 15: Global Glycomics Market Revenue (US$ Mn), by Drug Discovery & Development, 2017–2031

    Figure 16: Global Glycomics Market Revenue (US$ Mn), by Oncology, 2017–2031

    Figure 17: Global Glycomics Market Revenue (US$ Mn), by Immunology, 2017–2031

    Figure 18: Global Glycomics Market Value (US$ Mn), by Others, 2017–2031

    Figure 19: Global Glycomics Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 20: Global Glycomics Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 21: Global Glycomics Market Revenue (US$ Mn), by Academic Research Institutes, 2017–2031

    Figure 22: Global Glycomics Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017–2031

    Figure 23: Global Glycomics Market Value (US$ Mn), by Contract Research Organizations, 2017–2031

    Figure 24: Global Glycomics Market Value Share Analysis, by Region, 2020 and 2031

    Figure 25: Global Glycomics Market Analysis, by Region

    Figure 26: North America Glycomics Market Analysis Value (US$ Mn) Forecast, 2017–2031

    Figure 27: North America Glycomics Market Analysis Value Share Analysis, by Country, 2020 and 2031

    Figure 28: North America Glycomics Market Analysis Attractiveness Analysis, by Country 2021–2031

    Figure 29: North America Glycomics Market Value Share Analysis, by Product Type, 2020 and 2031

    Figure 30: North America Glycomics Market Attractiveness Analysis, by Product Type , 2021–2031

    Figure 31: North America Glycomics Market Value Share Analysis, by Application, 2020 and 2031

    Figure 32: North America Glycomics Market Attractiveness Analysis, by Application, 2021–2031

    Figure 33: North America Glycomics Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 34: North America Glycomics Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 35: Europe Glycomics Market Analysis Value (US$ Mn) Forecast, 2017–2031

    Figure 36: Europe Glycomics Market Analysis Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 37: Europe Glycomics Market Analysis Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 38: Europe Glycomics Market Value Share Analysis, by Product Type,

    Figure 39: Europe Glycomics Market Attractiveness Analysis, by Product Type, 2021–2031

    Figure 40: Europe Glycomics Market Value Share Analysis, by Application, 2020 and 2031

    Figure 41: Europe Glycomics Market Attractiveness Analysis, by Application, 2021–2031

    Figure 42: Europe Glycomics Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 43: Europe Glycomics Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 44: Asia Pacific Glycomics Market Analysis Value (US$ Mn) Forecast, 2017–2031

    Figure 45: Asia Pacific Glycomics Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 46: Asia Pacific Glycomics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 47: Asia Pacific Glycomics Market Value Share Analysis, by Product Type, 2020 and 2031

    Figure 48: Asia Pacific Glycomics Market Attractiveness Analysis, by Product Type, 2021–2031

    Figure 49: Asia Pacific Glycomics Market Value Share Analysis, by Application, 2020 and 2031

    Figure 50: Asia Pacific Glycomics Market Attractiveness Analysis, by Application, 2021–2031

    Figure 51: Asia Pacific Glycomics Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 52: Asia Pacific Glycomics Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 53: Latin America Glycomics Market Analysis Value (US$ Mn) Forecast, 2017–2031

    Figure 54: Latin America Glycomics Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 55: Latin America Glycomics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 56: Latin America Glycomics Market Value Share Analysis, by Product Type, 2020 and 2031

    Figure 57: Latin America Glycomics Market Attractiveness Analysis, by Product Type, 2021–2031

    Figure 58: Latin America Glycomics Market Value Share Analysis, by Application, 2020 and 2031

    Figure 59: Latin America Glycomics Market Attractiveness Analysis, by Application, 2021–2031

    Figure 60: Latin America Glycomics Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 61: Latin America Glycomics Market Attractiveness Analysis, by End-user, 2021–2031

    Figure 62: Middle East & Africa Glycomics Market Analysis Value (US$ Mn) Forecast, 2017–2031

    Figure 63: Middle East & Africa Glycomics Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

    Figure 64: Middle East & Africa Glycomics Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

    Figure 65: Middle East & Africa Glycomics Market Value Share Analysis, by Product Type, 2020 and 2031

    Figure 66: Middle East & Africa Glycomics Market Attractiveness Analysis, by Product Type, 2021–2031

    Figure 67: Middle East & Africa Glycomics Market Value Share Analysis, by Application, 2020 and 2031

    Figure 68: Middle East & Africa Glycomics Market Attractiveness Analysis, by Application, 2021–2031

    Figure 69: Middle East & Africa Glycomics Market Value Share Analysis, by End-user, 2020 and 2031

    Figure 70: Middle East & Africa Glycomics Market Attractiveness Analysis, by End-user, 2021–2031

Copyright © Transparency Market Research, Inc. All Rights reserved